Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions: an optical coherence tomography analysis

Autor: Alexandre Hideo-Kajita, Jouke Dijkstra, Pedro A. Lemos, Ralph Tölg, Yuichi Ozaki, Clemens von Birgelen, Javier Escaned, Evald Høj Christiansen, Hector M. Garcia-Garcia, William Wijns, Hüseyin Ince, Kayode O. Kuku, Michael Haude, Alexandre Abizaid, Ron Waksman
Přispěvatelé: Health Technology & Services Research
Rok vydání: 2018
Předmět:
Male
Scaffold
MULTICENTER
Drug-eluting absorbable metal scaffold
030204 cardiovascular system & hematology
0302 clinical medicine
Absorbable Implants
BIOSOLVE-II
Prospective Studies
OUTCOMES
BIORESORBABLE SCAFFOLDS
Luminal volume loss
medicine.diagnostic_test
Drug-Eluting Stents
Equipment Design
General Medicine
STENTS
Middle Aged
Coronary Vessels
INSIGHTS
medicine.anatomical_structure
luminal volume loss
Coronary vessel
Female
drug-eluting absorbable metal scaffold
Cardiology and Cardiovascular Medicine
Volume loss
Tomography
Optical Coherence

Artery
Adult
03 medical and health sciences
Optical coherence tomography
Side branch
medicine
Humans
Optical Coherence Tomography (OCT)
Radiology
Nuclear Medicine and imaging

In patient
DREAMS
Aged
Sirolimus
Wound Healing
optical coherence tomography
business.industry
PERFORMANCE
SUSTAINED SAFETY
n/a OA procedure
Nuclear medicine
business
Bioresorbable scaffold
Zdroj: European Heart Journal Cardiovascular Imaging, 20(8), 916-924. Oxford University Press
Ozaki, Y, Garcia-Garcia, H M, Hideo-Kajita, A, Kuku, K O, Haude, M, Ince, H, Abizaid, A, Tölg, R, Lemos, P A, von Birgelen, C, Christiansen, E H, Wijns, W, Escaned, J, Dijkstra, J & Waksman, R 2019, ' Impact of procedural characteristics on coronary vessel wall healing following implantation of second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary artery lesions : an optical coherence tomography analysis ', European Heart Journal Cardiovascular Imaging, vol. 20, no. 8, pp. 916-924 . https://doi.org/10.1093/ehjci/jey210
European Heart Journal-Cardiovascular Imaging, 20(8), 916-924
ISSN: 2047-2412
2047-2404
DOI: 10.1093/ehjci/jey210
Popis: Aims Second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) is an alternative novel device for treating coronary lesions. However, the relationship between in-scaffold dimensions after implantation of DREAMS 2G and vessel healing and luminal results at follow-up is unknown. The aim of this study is, therefore, to investigate whether the expansion index after implantation of DREAMS 2G as assessed by optical coherence tomography (OCT) impacts late luminal status and healing of the vessel wall. Methods and results This study comprises of a total 65 out of 123 patients who were enrolled in the BIOSOLVE-II trial. We assessed both qualitative and quantitative OCT findings and the expansion index of DREAMS 2G after implantation frame by frame using OCT. Expansion index was defined as minimum scaffold area/mean reference lumen area. The over-expansion group was also defined with expansion index >1.0. The total number of analysed frames at post-procedure and 6-month follow-up was 8243 and 8263 frames, respectively. At 6-month follow-up, in-scaffold healing was documented by the reduction of 82% in dissections, 93% in attached intra-luminal mass (ILM), 65% in non-attached ILM, and 76% in jailed side branch. The over-expansion group had significantly greater in-scaffold luminal volume loss (LVL) compared with the non-over-expansion group [over-expansion: 35.0 (18.5–52.1) mm3 vs. non-over-expansion: 21.0 (11.6–37.9) mm3, P = 0.039]. Conclusion Excellent in vivo healing process after implantation of DREAMS 2G was observed at 6 months. We found that higher expansion indices were associated with higher in-scaffold LVL at 6 months assessed by OCT.
Databáze: OpenAIRE